Trends in mean serum insulin and hyperinsulinemia among US adults without diabetes 1999-2018

J Diabetes Complications. 2025 Nov;39(11):109159. doi: 10.1016/j.jdiacomp.2025.109159. Epub 2025 Aug 28.

Abstract

Purpose: The purpose of this study is to examine trends for mean serum insulin concentration (pmol/L) and prevalence of hyperinsulinemia (≥4.358 pmol/L fasting insulin) in US adults without diabetes.

Methods: We used data from the 1999-2018 National Health and Nutrition Examination Survey (NHANES). Participants (n = 14,150) were ≥20 years of age, not pregnant, had no history of diabetes, had a fasting blood glucose measure of less than 126 mg/dL, and had valid responses to all study variables. Consecutive cycles of NHANES data from 1999 to 2018 (20 years) were aggregated into five four-year intervals.

Results: The Annual Percent Change (APC) for mean fasting insulin ranged from 5.64 (adjusted for body mass index) to 7.65 % when unadjusted (all p-values for trend <0.0001). The APC for hyperinsulinemia prevalence ranged from 19.4 % (adjusted for waist circumference) to 22.3 % when unadjusted (all p-values for trend <0.0001). The subanalyses by gender consistently revealed significant positive trends for both outcomes.

Conclusions: This study illustrates a significant positive trend for mean fasting insulin concentrations and hyperinsulinemia among US adults over 20 years. Monitoring serum insulin and hyperinsulinemia trends provides insights into the continuing rise in type 2 diabetes (T2D) and opportunities for T2D prevention.

Keywords: Cross-sectional studies; Hyperinsulinism; Insulin; Type 2 diabetes mellitus.

MeSH terms

  • Adult
  • Aged
  • Blood Glucose / analysis
  • Body Mass Index
  • Fasting / blood
  • Female
  • Humans
  • Hyperinsulinism* / blood
  • Hyperinsulinism* / epidemiology
  • Insulin* / blood
  • Male
  • Middle Aged
  • Nutrition Surveys
  • Prevalence
  • United States / epidemiology
  • Young Adult

Substances

  • Insulin
  • Blood Glucose